Patienterne bør monitoreres nøje for at sikre, at den lavest godkendte dosis af Retacrit anvendes til at sørge for tilstrækkelig kontrol af de anæmiske symptomer. ###>Patients should be monitored closely to ensure that the lowest approved dose of Retacrit is used to provide adequate control of the symptoms of anaemia.